 Evelo expects to grant the underwriters a 30-day option, solely to cover over-allotments, if any, to purchase up to an additional 6 million of its common stock. All of the shares in the proposed offering are to be sold by Evelo. Morgan Stanley, Cowen and BMO Capital Markets are acting as joint book-running managers for the offering. 